Denna sida på svenska

Markus Maeurer

Professor/senior physician

Organisational affiliation

TIM

Department

Department of Laboratory Medicine (LABMED), H5

Delivery address : Huddinge, Sweden

Publications

Expansion of Tumor-reactive T Cells From Patients With Pancreatic Cancer
Meng Q, Liu Z, Rangelova E, Poiret T, Ambati A, Rane L, et al
Journal of immunotherapy (Hagerstown, Md. : 1997) 2016;39(2):81-9

Host-directed therapies for antimicrobial resistant respiratory tract infections
Maeurer M, Rao M, Zumla A
Current opinion in pulmonary medicine 2016;22(3):203-11

Host-directed therapies for infectious diseases: current status, recent progress, and future prospects
Zumla A, Rao M, Wallis Rs, Kaufmann Sh, Rustomjee R, Mwaba P, et al
The Lancet. Infectious diseases 2016;16(4):e47-63

Host-directed therapies for infectious diseases: current status, recent progress, and future prospects
Host-directed Therapies Network, Zumla A, Rao M, Wallis Rs, Kaufmann She, Rustomjee R, et al
LANCET INFECTIOUS DISEASES 2016;16(4):E47-E63

No Evidence for Disease History as a Risk Factor for Narcolepsy after A(H1N1)pdm09 Vaccination
Lamb F, Ploner A, Fink K, Maeurer M, Bergman P, Piehl F, et al
PloS one 2016;11(4):e0154296-

Projected variations in the regional clustering of precipitation stations around Chicago
Um Mj, Markus M, Wuebbles Dj, Kim Y
CLIMATE RESEARCH 2016;67(2):151-163

Taking forward the World TB Day 2016 theme 'Unite to End Tuberculosis' for the WHO Africa Region
Ntoumi F, Kaleebu P, Macete E, Mfinanga S, Chakaya J, Yeboah-manu D, et al
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases 2016;46():34-7

Tuberculosis--advances in development of new drugs, treatment regimens, host-directed therapies, and biomarkers
Wallis Rs, Maeurer M, Mwaba P, Chakaya J, Rustomjee R, Migliori Gb, et al
The Lancet. Infectious diseases 2016;16(4):e34-46

Tuberculosis-advances in development of new drugs, treatment regimens, host-directed therapies, and biomarkers
Wallis Rs, Maeurer M, Mwaba P, Chakaya J, Rustomjee R, Migliori Gb, et al
LANCET INFECTIOUS DISEASES 2016;16(4):E34-E46

World TB Day 2016: reflections on the global TB emergency
Zumla A, Schito M, Chakaya J, Marais B, Mwaba P, Migliori Gb, et al
LANCET RESPIRATORY MEDICINE 2016;4(4):249-51

A coordinated cross-disciplinary research initiative to address an increased incidence of narcolepsy following the 2009-2010 Pandemrix vaccination programme in Sweden
Feltelius N, Persson I, Ahlqvist-rastad J, Andersson M, Arnheim-dahlström L, Bergman P, et al
Journal of internal medicine 2015;278(4):335-53

B in TB: B Cells as Mediators of Clinically Relevant Immune Responses in Tuberculosis
Rao M, Valentini D, Poiret T, Dodoo E, Parida S, Zumla A, et al
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2015;61Suppl 3():S225-34

Burden of tuberculosis at post mortem in inpatients at a tertiary referral centre in sub-Saharan Africa: a prospective descriptive autopsy study
Bates M, Mudenda V, Shibemba A, Kaluwaji J, Tembo J, Kabwe M, et al
The Lancet. Infectious diseases 2015;15(5):544-51

Cellular therapy in tuberculosis
Parida Sk, Madansein R, Singh N, Padayatchi N, Master I, Naidu K, et al
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases 2015;32():32-8

Commemorating World Tuberculosis Day 2015
Zumla A, Maeurer M, Marais B, Chakaya J, Wejse C, Lipman M, et al
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases 2015;32():1-4

Corticosteroid therapy for pneumonia
Zumla A, Bates M, Maeurer M
Lancet (London, England) 2015;386(9997):955-

Evaluation of pretransplant influenza vaccination in hematopoietic SCT: a randomized prospective study
Ambati A, Boas Ls, Ljungman P, Testa L, De Oliveira Jf, Aoun M, et al
Bone marrow transplantation 2015;50(6):858-64

Frequency of Mycobacterium tuberculosis-specific CD8+ T-cells in the course of anti-tuberculosis treatment
Axelsson-robertson R, Rao M, Loxton Ag, Walzl G, Bates M, Zumla A, et al
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases 2015;32():23-9

H1N1 viral proteome peptide microarray predicts individuals at risk for H1N1 infection and segregates infection versus Pandemrix(®) vaccination
Ambati A, Valentini D, Montomoli E, Lapini G, Biuso F, Wenschuh H, et al
Immunology 2015;145(3):357-66

Host-directed therapies for improving poor treatment outcomes associated with the middle east respiratory syndrome coronavirus infections
Zumla A, Azhar Ei, Arabi Y, Alotaibi B, Rao M, Mccloskey B, et al
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases 2015;40():71-4

Host-Directed Therapies for Tackling Multi-Drug Resistant Tuberculosis: Learning From the Pasteur-Bechamp Debates
Zumla A, Maeurer M, Host-directed Therapies Network (hdt-net) Consortium
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2015;61(9):1432-8

Host-directed therapies for tuberculous pericarditis
Zumla A, Maeurer M, Moll G, Mayosi Bm
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases 2015;32():30-1

Host directed therapies (HDTs) and immune response signatures: insights into a role for interleukin-32
Maeurer M, Rao M, Zumla A
Annals of translational medicine 2015;3(Suppl 1):S37-

Host-directed therapy: tuberculosis vaccine development
Rao M, Zumla A, Maeurer M
The Lancet. Respiratory medicine 2015;3(3):172-3

IFN-γ Release Assays for Risk Assessment in Contacts of Patients with Tuberculosis in Low-Burden European Countries
Zumla A, Maeurer M
American journal of respiratory and critical care medicine 2015;191(10):1101-3

Immunogenicity of virosomal adjuvanted trivalent influenza vaccination in allogeneic stem cell transplant recipients
Ambati A, Einarsdottir S, Magalhaes I, Poiret T, Bodenstein R, Leblanc K, et al
Transplant infectious disease : an official journal of the Transplantation Society 2015;17(3):371-9

Increased β-haemolytic group A streptococcal M6 serotype and streptodornase B-specific cellular immune responses in Swedish narcolepsy cases
Ambati A, Poiret T, Svahn Bm, Valentini D, Khademi M, Kockum I, et al
Journal of internal medicine 2015;278(3):264-76

Inflammation and tuberculosis: host-directed therapies
Zumla A, Rao M, Parida Sk, Keshavjee S, Cassell G, Wallis R, et al
Journal of internal medicine 2015;277(4):373-87

Middle East Respiratory Syndrome--need for increased vigilance and watchful surveillance for MERS-CoV in sub-Saharan Africa
Zumla A, Rustomjee R, Ntoumi F, Mwaba P, Bates M, Maeurer M, et al
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases 2015;37():77-9

Mycobacterium tuberculosis-specific and MHC class I-restricted CD8+ T-cells exhibit a stem cell precursor-like phenotype in patients with active pulmonary tuberculosis
Axelsson-robertson R, Ju Jh, Kim Hy, Zumla A, Maeurer M
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases 2015;32():13-22

Perspectives on Advances in Tuberculosis Diagnostics, Drugs, and Vaccines
Schito M, Migliori Gb, Fletcher Ha, Mcnerney R, Centis R, D'ambrosio L, et al
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2015;61Suppl 3():S102-18

Perspectives on tuberculosis in pregnancy
Bates M, Ahmed Y, Kapata N, Maeurer M, Mwaba P, Zumla A
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases 2015;32():124-7

Serum reactome induced by Bordetella pertussis infection and Pertussis vaccines: qualitative differences in serum antibody recognition patterns revealed by peptide microarray analysis
Valentini D, Ferrara G, Advani R, Hallander Ho, Maeurer Mj
BMC immunology 2015;16():40-

Standardized Screening for Mental Health Needs of Detained Youths from Various Ethnic Origins: The Dutch Massachusetts Youth Screening Instrument-Second Version (MAYSI-2)
Colins Of, Grisso T, Vahl P, Guy L, Mulder E, Hornby N, et al
JOURNAL OF PSYCHOPATHOLOGY AND BEHAVIORAL ASSESSMENT 2015;37(3):481-492

Surgical treatment of complications of pulmonary tuberculosis, including drug-resistant tuberculosis
Madansein R, Parida S, Padayatchi N, Singh N, Master I, Naidu K, et al
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases 2015;32():61-7

T-Cell Therapy: Options for Infectious Diseases
Parida Sk, Poiret T, Zhenjiang L, Meng Q, Heyckendorf J, Lange C, et al
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2015;61Suppl 3():S217-24

The history of tuberculosis management in Sweden
Wallstedt H, Maeurer M
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases 2015;32():179-82

Totally drug-resistant tuberculosis and adjunct therapies
Parida Sk, Axelsson-robertson R, Rao Mv, Singh N, Master I, Lutckii A, et al
Journal of internal medicine 2015;277(4):388-405

Towards host-directed therapies for tuberculosis
Zumla A, Maeurer M, Host-directed Therapies Network, Chakaya J, Hoelscher M, Ntoumi F, et al
Nature reviews. Drug discovery 2015;14(8):511-2

Translating the Tuberculosis Research Agenda: Much Accomplished, but Much More to Be Done
Schito M, Maeurer M, Kim P, Hanna D, Zumla A
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2015;61Suppl 3():S95-101

Tuberculosis treatment and management--an update on treatment regimens, trials, new drugs, and adjunct therapies
Zumla A, Chakaya J, Centis R, D'ambrosio L, Mwaba P, Bates M, et al
The Lancet. Respiratory medicine 2015;3(3):220-34

Why healthcare workers are sick of TB
Von Delft A, Dramowski A, Khosa C, Kotze K, Lederer P, Mosidi T, et al
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases 2015;32():147-51

Advancing the portfolio of tuberculosis diagnostics, drugs, biomarkers, and vaccines
Zumla Ai, Schito M, Maeurer M
The Lancet. Infectious diseases 2014;14(4):267-9

A/H1N1 antibodies and TRIB2 autoantibodies in narcolepsy patients diagnosed in conjunction with the Pandemrix vaccination campaign in Sweden 2009-2010
Lind A, Ramelius A, Olsson T, Arnheim-dahlström L, Lamb F, Khademi M, et al
Journal of autoimmunity 2014;50():99-106

Allogeneic Hematopoietic Cell Transplantation for GATA2 Deficiency in a Patient With Disseminated Human Papillomavirus Disease
Maeurer M, Magalhaes I, Andersson J, Ljungman P, Sandholm E, Uhlin M, et al
Transplantation 2014;98(12):e95-6

Analysis of a changing hydrologic flood regime using the Variable Infiltration Capacity model
Park D, Markus M
JOURNAL OF HYDROLOGY 2014;:267-280

Autologous mesenchymal stromal cell infusion as adjunct treatment in patients with multidrug and extensively drug-resistant tuberculosis: an open-label phase 1 safety trial
Skrahin A, Ahmed Rk, Ferrara G, Rane L, Poiret T, Isaikina Y, et al
The Lancet. Respiratory medicine 2014;2(2):108-22

Difference in immune response in vaccinated and unvaccinated Swedish individuals after the 2009 influenza pandemic
Magalhaes I, Eriksson M, Linde C, Muhammad R, Rane L, Ambati A, et al
BMC infectious diseases 2014;14():319-

Emerging novel and antimicrobial-resistant respiratory tract infections: new drug development and therapeutic options
Zumla A, Memish Za, Maeurer M, Bates M, Mwaba P, Al-tawfiq Ja, et al
The Lancet. Infectious diseases 2014;14(11):1136-49

New antituberculosis drugs, regimens, and adjunct therapies: needs, advances, and future prospects
Zumla Ai, Gillespie Sh, Hoelscher M, Philips Pp, Cole St, Abubakar I, et al
The Lancet. Infectious diseases 2014;14(4):327-40

Pregnancy and infection
Zumla A, Bates M, Maeurer M
The New England journal of medicine 2014;371(11):1076-

Progress in tuberculosis vaccine development and host-directed therapies--a state of the art review
Kaufmann Sh, Lange C, Rao M, Balaji Kn, Lotze M, Schito M, et al
The Lancet. Respiratory medicine 2014;2(4):301-20

Rapid point of care diagnostic tests for viral and bacterial respiratory tract infections--needs, advances, and future prospects
Zumla A, Al-tawfiq Ja, Enne Vi, Kidd M, Drosten C, Breuer J, et al
The Lancet. Infectious diseases 2014;14(11):1123-35

Reduced IL-7 responsiveness defined by signal transducer and activator of transcription 5 phosphorylation in T cells may be a marker for increased risk of developing cytomegalovirus disease in patients after hematopoietic stem cell transplantation
Pérez-bercoff L, Vudattu Nk, Byrareddy Sn, Mattsson J, Maeurer M, Ljungman P
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2014;20(1):128-32

Reduced plasma levels of soluble interleukin-7 receptor during graft-versus-host disease (GVHD) in children and adults
Poiret T, Rane L, Remberger M, Omazic B, Gustafsson-jernberg A, Vudattu Nk, et al
BMC immunology 2014;15():25-

Risk factors for Epstein-Barr virus-related post-transplant lymphoproliferative disease after allogeneic hematopoietic stem cell transplantation
Uhlin M, Wikell H, Sundin M, Blennow O, Maeurer M, Ringden O, et al
Haematologica 2014;99(2):346-52

Short communication: HIV-1 Nef protein carries multiple epitopes suitable for induction of cellular immunity for an HIV vaccine in Africa
Kilpeläinen A, Axelsson Robertson R, Leitner T, Sandström E, Maeurer M, Wahren B
AIDS research and human retroviruses 2014;30(11):1065-71

TCR+CD4-CD8- T cells in antigen-specific MHC class I-restricted T-cell responses after allogeneic hematopoietic stem cell transplantation
Ahmed Rk, Poiret T, Ambati A, Rane L, Remberger M, Omazic B, et al
Journal of immunotherapy (Hagerstown, Md. : 1997) 2014;37(8):416-25

The Hajj pilgrimage and surveillance for Middle East Respiratory syndrome coronavirus in pilgrims from African countries
Zumla A, Mwaba P, Bates M, Al-tawfiq Ja, Maeurer M, Memish Za
Tropical medicine & international health : TM & IH 2014;19(7):838-40

The host battles drug-resistant tuberculosis
Maeurer M, Zumla A
Science translational medicine 2014;6(263):263fs47-

Totally-drug-resistant tuberculosis: hype versus hope
Maeurer M, Schito M, Zumla A
The Lancet. Respiratory medicine 2014;2(4):256-7

Whole CMV proteome pattern recognition analysis after HSCT identifies unique epitope targets associated with the CMV status
Pérez-bercoff L, Valentini D, Gaseitsiwe S, Mahdavifar S, Schutkowski M, Poiret T, et al
PloS one 2014;9(4):e89648-

A broad profile of co-dominant epitopes shapes the peripheral Mycobacterium tuberculosis specific CD8+ T-cell immune response in South African patients with active tuberculosis
Axelsson-robertson R, Loxton Ag, Walzl G, Ehlers Mm, Kock Mm, Zumla A, et al
PloS one 2013;8(3):e58309-

Advances in tuberculosis diagnostics: the Xpert MTB/RIF assay and future prospects for a point-of-care test
Lawn Sd, Mwaba P, Bates M, Piatek A, Alexander H, Marais Bj, et al
The Lancet. Infectious diseases 2013;13(4):349-61

Assessment of the Xpert MTB/RIF assay for diagnosis of tuberculosis with gastric lavage aspirates in children in sub-Saharan Africa: a prospective descriptive study
Bates M, O'grady J, Maeurer M, Tembo J, Chilukutu L, Chabala C, et al
LANCET INFECTIOUS DISEASES 2013;13(1):36-42

BCG-specific IgG-secreting peripheral plasmablasts as a potential biomarker of active tuberculosis in HIV negative and HIV positive patients
Ashenafi S, Aderaye G, Zewdie M, Raqib R, Bekele A, Magalhaes I, et al
Thorax 2013;68(3):269-76

Differential cellular recognition pattern to M. tuberculosis targets defined by IFN-gamma and IL-17 production in blood from TB plus patients from Honduras as compared to health care workers: TB and immune responses in patients from Honduras
Alvarez-corrales N, Ahmed Rk, Rodriguez Ca, Balaji Kn, Rivera R, Sompallae R, et al
BMC INFECTIOUS DISEASES 2013;:125-

Drug-resistant tuberculosis: time for visionary political leadership
Abubakar I, Zignol M, Falzon D, Raviglione M, Ditiu L, Masham S, et al
The Lancet. Infectious diseases 2013;13(6):529-39

Progress and challenges in childhood tuberculosis
Marais Bj, Graham Sm, Maeurer M, Zumla A
The Lancet. Infectious diseases 2013;13(4):287-9

Rapid diagnostics urgently needed for killer infections
Zumla A, Gant V, Bates M, Mwaba P, Maeurer M, Memish Za
The Lancet. Respiratory medicine 2013;1(4):284-5

Systems level immune response analysis and personalized medicine
Brodin P, Valentini D, Uhlin M, Mattsson J, Zumla A, Maeurer Mj
Expert review of clinical immunology 2013;9(4):307-17

Tuberculosis biomarkers discovery: developments, needs, and challenges
Wallis Rs, Kim P, Cole S, Hanna D, Andrade Bb, Maeurer M, et al
The Lancet. Infectious diseases 2013;13(4):362-72

Tuberculosis comorbidity with communicable and non-communicable diseases: integrating health services and control efforts
Marais Bj, Lönnroth K, Lawn Sd, Migliori Gb, Mwaba P, Glaziou P, et al
The Lancet. Infectious diseases 2013;13(5):436-48

Use of the Xpert(®) MTB/RIF assay for diagnosing pulmonary tuberculosis comorbidity and multidrug-resistant TB in obstetrics and gynaecology inpatient wards at the University Teaching Hospital, Lusaka, Zambia
Bates M, Ahmed Y, Chilukutu L, Tembo J, Cheelo B, Sinyangwe S, et al
Tropical medicine & international health : TM & IH 2013;18(9):1134-40

Zero deaths from tuberculosis: progress, reality, and hope
Zumla A, Kim P, Maeurer M, Schito M
The Lancet. Infectious diseases 2013;13(4):285-7

Adjunct Immunotherapies for Tuberculosis
Uhlin M, Andersson J, Zumla A, Maeurer M
JOURNAL OF INFECTIOUS DISEASES 2012;:S325-34

Drug-Resistant Tuberculosis-Current Dilemmas, Unanswered Questions, Challenges, and Priority Needs
Zumla A, Abubakar I, Raviglione M, Hoelscher M, Ditiu L, Mchugh Td, et al
JOURNAL OF INFECTIOUS DISEASES 2012;:S228-40

Eliminating Tuberculosis and Tuberculosis-HIV Co-Disease in the 21st Century: Key Perspectives, Controversies, Unresolved Issues, and Needs
Zumla A, Atun R, Maeurer M, Kim Ps, Jean-philippe P, Hafner R, et al
JOURNAL OF INFECTIOUS DISEASES 2012;:S141-6

Evaluation of the Burden of Unsuspected Pulmonary Tuberculosis and Co-Morbidity with Non-Communicable Diseases in Sputum Producing Adult Inpatients
Bates M, O'grady J, Mwaba P, Chilukutu L, Mzyece J, Cheelo B, et al
PLOS ONE 2012;7(7):e40774-

Evaluation of the Xpert MTB/RIF Assay at a Tertiary Care Referral Hospital in a Setting Where Tuberculosis and HIV Infection Are Highly Endemic
O'grady J, Bates M, Chilukutu L, Mzyece J, Cheelo B, Chilufya M, et al
CLINICAL INFECTIOUS DISEASES 2012;55(9):1171-8

Generation of T-cell receptors targeting a genetically stable and immunodominant cytotoxic T-lymphocyte epitope within hepatitis C virus non-structural protein 3
Pasetto A, Frelin L, Brass A, Yasmeen A, Koh S, Lohmann V, et al
JOURNAL OF GENERAL VIROLOGY 2012;:247-58

Immune responses to ESAT-6 and CFP-10 by FASCIA and multiplex technology for diagnosis of M. tuberculosis infection; IP-10 is a promising marker
Borgström E, Andersen P, Atterfelt F, Julander I, Källenius G, Maeurer M, et al
PloS one 2012;7(11):e43438-

Intravenous immunoglobulin (IVIg) for refractory and difficult-to-treat infections
Ferrara G, Zumla A, Maeurer M
The American journal of medicine 2012;125(10):1036.e1-8

Pattern recognition and cellular immune responses to novel Mycobacterium tuberculosis-antigens in individuals from Belarus
Ahmed Rk, Rohava Z, Balaji Kn, Hoffner Se, Gaines H, Magalhaes I, et al
BMC INFECTIOUS DISEASES 2012;:41-

Phase I clinical trial of mixed bacterial vaccine (Coley's toxins) in patients with NY-ESO-1 expressing cancers: immunological effects and clinical activity
Karbach J, Neumann A, Brand K, Wahle C, Siegel E, Maeurer M, et al
Clinical cancer research : an official journal of the American Association for Cancer Research 2012;18(19):5449-59

Prime-boost vaccination with rBCG/rAd35 enhances CD8⁺ cytolytic T-cell responses in lesions from Mycobacterium tuberculosis-infected primates
Rahman S, Magalhaes I, Rahman J, Ahmed Rk, Sizemore Dr, Scanga Ca, et al
Molecular medicine (Cambridge, Mass.) 2012;18():647-58

Rapid salvage treatment with virus-specific T cells for therapy-resistant disease
Uhlin M, Gertow J, Uzunel M, Okas M, Berglund S, Watz E, et al
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2012;55(8):1064-73

Rational Development of Adjunct Immune-Based Therapies for Drug-Resistant Tuberculosis: Hypotheses and Experimental Designs
Zumla A, Maeurer M
JOURNAL OF INFECTIOUS DISEASES 2012;:S335-9

Risk factors associated with pulmonary tuberculosis: smoking, diabetes and anti-TNF alpha drugs
Ferrara G, Murray M, Winthrop K, Centis R, Sotgiu G, Migliori Gb, et al
CURRENT OPINION IN PULMONARY MEDICINE 2012;18(3):233-40

The Immunological Footprint of Mycobacterium tuberculosis T-cell Epitope Recognition
Axelsson-robertson R, Magalhaes I, Parida Sk, Zumla A, Maeurer M
JOURNAL OF INFECTIOUS DISEASES 2012;:S301-15

Tuberculosis and Tuberculosis/HIV/AIDS-Associated Mortality in Africa: The Urgent Need to Expand and Invest in Routine and Research Autopsies
Mudenda V, Lucas S, Shibemba A, O'grady J, Bates M, Kapata N, et al
JOURNAL OF INFECTIOUS DISEASES 2012;:S340-6

Tuberculosis Diagnostics and Biomarkers: Needs, Challenges, Recent Advances, and Opportunities
Mcnerney R, Maeurer M, Abubakar I, Marais B, Mchugh Td, Ford N, et al
JOURNAL OF INFECTIOUS DISEASES 2012;:S147-58

Update on viral infections in lung transplantation
Uhlin M, Mattsson J, Maeurer M
CURRENT OPINION IN PULMONARY MEDICINE 2012;18(3):264-70

Achieving STOP TB Partnership goals: perspectives on development of new diagnostics, drugs and vaccines for tuberculosis
Mwaba P, Mcnerney R, Grobusch Mp, O'grady J, Bates M, Kapata N, et al
TROPICAL MEDICINE & INTERNATIONAL HEALTH 2011;16(7):819-27

A Decade of Interferon-gamma Release Assays: Quest for the Holy Grail to Diagnose Latent Infection with Mycobacterium tuberculosis?
Ferrara G, Parida Sk, Zumla A, Richeldi L, Maeurer M
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE 2011;183(12):1732-

Decreased IL-7 Signaling in T Cells From Patients With PTLD After Allogeneic HSCT
Omar H, Ahmed R, Rane L, Bjorklund A, Gustafsson-jernberg A, Ljungman P, et al
JOURNAL OF IMMUNOTHERAPY 2011;34(4):390-6

Detection of proliferative responses to ESAT-6 and CFP-10 by FASCIA assay for diagnosis of Mycobacterium tuberculosis infection
Borgstrom E, Andersen P, Andersson L, Julander I, Kallenius G, Maeurer M, et al
JOURNAL OF IMMUNOLOGICAL METHODS 2011;370(1-2):55-64

Helicobacter pylori defines local immune response through interaction with dendritic cells
Andres S, Schmidt Hma, Mitchell H, Rhen M, Maeurer M, Engstrand L
FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY 2011;61(2):168-78

Human Leukocyte Antigens A*3001 and A*3002 Show Distinct Peptide-Binding Patterns of the Mycobacterium tuberculosis Protein TB10.4: Consequences for Immune Recognition
Axelsson-robertson R, Ahmed Rk, Weichold Ff, Ehlers Mm, Kock Mm, Sizemore D, et al
CLINICAL AND VACCINE IMMUNOLOGY 2011;18(1):125-34

Increased (6 exon) interleukin-7 production after M. tuberculosis infection and soluble interleukin-7 receptor expression in lung tissue
Rane L, Rahman S, Magalhaes I, Ahmed R, Spangberg M, Kondova I, et al
GENES AND IMMUNITY 2011;12(7):513-22

LifeGene-a large prospective population-based study of global relevance
Almqvist C, Adami Ho, Franks Pw, Groop L, Ingelsson E, Kere J, et al
EUROPEAN JOURNAL OF EPIDEMIOLOGY 2011;26(1):67-77

New and improved diagnostics for detection of drug-resistant pulmonary tuberculosis
O'grady J, Maeurer M, Mwaba P, Kapata N, Bates M, Hoelscher M, et al
CURRENT OPINION IN PULMONARY MEDICINE 2011;17(3):134-41

Potential confounders in observed association between coeliac disease and tuberculosis: authors' reply
Ludvigsson Jf, Sanders Ds, Maeurer M, Jonsson J, Grunewald J, Wahlstrom J
ALIMENTARY PHARMACOLOGY & THERAPEUTICS 2011;33(10):1176-+

Risk of tuberculosis in a large sample of patients with coeliac disease - a nationwide cohort study
Ludvigsson Jf, Sanders Ds, Maeurer M, Jonsson J, Grunewald J, Wahlstrom J
ALIMENTARY PHARMACOLOGY & THERAPEUTICS 2011;33(6):689-96

Screening of immigrants in the UK for latent tuberculosis
Mcnerney R, Ferrara G, O'grady J, Maeurer M, Zumla A
EXPERT REVIEW OF RESPIRATORY MEDICINE 2011;5(4):483-6

Tuberculosis in prisons: anatomy of global neglect
O'grady J, Maeurer M, Atun R, Abubakar I, Mwaba P, Bates M, et al
EUROPEAN RESPIRATORY JOURNAL 2011;38(4):752-4

Tuberculosis in prisons in sub-Saharan Africa - the need for improved health services, surveillance and control
O'grady J, Hoelscher M, Atun R, Bates M, Mwaba P, Kapata N, et al
TUBERCULOSIS 2011;91(2):173-8

Viewpoint: Scientific dogmas, paradoxes and mysteries of latent Mycobacterium tuberculosis infection
Zumla A, Atun R, Maeurer M, Mwaba P, Ma Z, O'grady J, et al
TROPICAL MEDICINE & INTERNATIONAL HEALTH 2011;16(1):79-83

Xpert MTB/RIF test for tuberculosis
Ferrara G, O'grady J, Zumla A, Maeurer M
LANCET 2011;378(9790):482-author

Alternative splicing of interleukin-7 (IL-7) and interleukin-7 receptor alpha (IL-7R alpha) in peripheral blood from patients with multiple sclerosis (MS)
Rane L, Vudattu N, Bourcier K, Graniar E, Hillert J, Seyfert V, et al
JOURNAL OF NEUROIMMUNOLOGY 2010;222(1-2):82-6

Extensive major histocompatibility complex class I binding promiscuity for Mycobacterium tuberculosis TB10.4 peptides and immune dominance of human leucocyte antigen (HLA)-B*0702 and HLA-B*0801 alleles in TB10.4 CD8+T-cell responses
Axelsson-robertson R, Weichold F, Sizemore D, Wulf M, Skeiky Yaw, Sadoff J, et al
IMMUNOLOGY 2010;129(4):496-505

High content cellular immune profiling reveals differences between rhesus monkeys and men
Magalhaes I, Vudattu Nk, Ahmed Rk, Kuhlmann-berenzon S, Ngo Y, Sizemore Dr, et al
IMMUNOLOGY 2010;131(1):128-40

Humoral 'reactome' profiles using peptide microarray chips
Valentini D, Gaseitsiwe S, Maeurer M
TRENDS IN IMMUNOLOGY 2010;31(11):399-400

IL-7 expression and responsiveness in EBV infection and EBV-associated PTLD in allogeneic HSCT patients
Omar H, Ahmed R, Rane L, Bjorklund A, Gustafsson-jemberg A, Ljungman P, et al
BONE MARROW TRANSPLANTATION 2010;:S210-S211

Interleukin-7 (IL-7) and IL-7 splice variants affect differentiation of human neural progenitor cells
Moors M, Vudattu Nk, Abel J, Kramer U, Rane L, Ulfig N, et al
GENES AND IMMUNITY 2010;11(1):11-20

Markus Maeurer on the LifeGene project
Maeurer M
EXPERT REVIEW OF CLINICAL IMMUNOLOGY 2010;6(5):709-12

Pattern recognition of the entire human Cytomegalovirus proteome after HSCT defined by high-content peptide microarray chip analysis
Perez-bercoff L, Ngo Y, Gaseitsiwe S, Valentini D, Mandavifar S, Schutkowski M, et al
BONE MARROW TRANSPLANTATION 2010;:S207-S207

Peptide Microarray-Based Identification of Mycobacterium tuberculosis Epitope Binding to HLA-DRB1*0101, DRB1*1501, and DRB1*0401
Gaseitsiwe S, Valentini D, Mahdavifar S, Reilly M, Ehrnst A, Maeurer M
CLINICAL AND VACCINE IMMUNOLOGY 2010;17(1):168-75

Clinical and microbiological efficacy of moxifloxacin versus amoxicillin/clavulanic acid in severe odontogenic abscesses: a pilot study
Al-nawas B, Walter C, Morbach T, Seitner N, Siegel E, Maeurer M, et al
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES 2009;28(1):75-82

Early Administration of Low Molecular Weight Heparin after Spontaneous Intracerebral Hemorrhage A Safety Analysis
Kiphuth Ic, Staykov D, Koehrmann M, Struffert T, Richter G, Bardutzky J, et al
CEREBROVASCULAR DISEASES 2009;27(2):146-50

Expression analysis and functional activity of interleukin-7 splice variants
Vudattu Nk, Magalhaes I, Hoehn H, Pan D, Maeurer Mj
GENES AND IMMUNITY 2009;10(2):132-40

Harmonization guidelines for HLA-peptide multimer assays derived from results of a large scale international proficiency panel of the Cancer Vaccine Consortium
Cvc-cri Immune Assay Working Grp, Britten Cm, Janetzki S, Ben-porat L, Clay Tm, Kalos M, et al
CANCER IMMUNOLOGY IMMUNOTHERAPY 2009;58(10):1701-13

Identification and testing of control peptides for antigen microarrays
Ngo Y, Advani R, Valentini D, Gaseitsiwe S, Mahdavifar S, Maeurer M, et al
JOURNAL OF IMMUNOLOGICAL METHODS 2009;343(2):68-78

Identification of MHC class II binding peptides: microarray and soluble MHC class II molecules
Gaseitsiwe S, Maeurer Mj
Methods in molecular biology (Clifton, N.J.) 2009;524():417-26

Increased Numbers of IL-7 Receptor Molecules on CD4+CD25-CD107a+T-Cells in Patients with Autoimmune Diseases Affecting the Central Nervous System
Vudattu Nk, Kuhlmann-berenzon S, Khademi M, Seyfert V, Olsson T, Maeurer Mj
PLOS ONE 2009;4(8):e6534-

Major Histocompatibility Complex Class II Molecule-Human Immunodeficiency Virus Peptide Analysis Using a Microarray Chip
Gaseitsiwe S, Valentini D, Ahmed R, Mahdavifar S, Magalhaes I, Zerweck J, et al
CLINICAL AND VACCINE IMMUNOLOGY 2009;16(4):567-73

QuantiFERON-TB GOLD ELISA assay for the detection of Mycobacterium tuberculosis-specific antigens in blood specimens of HIV-positive patients in a high-burden country
Veldsman C, Kock Mm, Rossouw T, Nieuwoudt M, Maeurer M, Hoosen Aa, et al
FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY 2009;57(3):269-73

T-cell epitope mapping
Ahmed Rk, Maeurer Mj
Methods in molecular biology (Clifton, N.J.) 2009;524():427-38

Pattern Recognition in Pulmonary Tuberculosis Defined by High Content Peptide Microarray Chip Analysis Representing 61 Proteins from M. tuberculosis
Gaseitsiwe S, Valentini D, Mahdavifar S, Magalhaes I, Hoft Df, Zerweck J, et al
PLOS ONE 2008;3(12):e3840-

rBCG Induces Strong Antigen-Specific T Cell Responses in Rhesus Macaques in a Prime-Boost Setting with an Adenovirus 35 Tuberculosis Vaccine Vector
Magalhaes I, Sizemore Dr, Ahmed Rk, Mueller S, Wehlin L, Scanga C, et al
PLOS ONE 2008;3(11):e3790-

Severe versus local odontogenic bacterial infections: Comparison of microbial isolates
Al-nawas B, Maeurer M
EUROPEAN SURGICAL RESEARCH 2008;40(2):220-4

Tumor Antigen-specific T-cells are Present in the CD8 alpha alpha(+) T-cell Effector-memory Pool
Magalhaes I, Vudattu Nk, Jager E, Maeurer Mj
JOURNAL OF IMMUNOTHERAPY 2008;31(9):840-8

High-content T-cell and B-cell analysis
Maeurer M
CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY 2007;32(1):75-84

Human papillomavirus 16 E6-specific CD45RA+ CCR7+ high avidity CD8(+) T cells fail to control tumor growth despite interferon-gamma production in patients with cervical cancer
Zehbe I, Kaufmann Am, Schmidt M, Hohn H, Maeurer Mj
JOURNAL OF IMMUNOTHERAPY 2007;30(5):523-32

Impact of MHC class I alleles on the M. tuberculosis antigen-specific CD8(+) T-cell response in patients with pulmonary tuberculosis
Weichold Ff, Mueller S, Kortsik C, Hitzler W, Wulf Mj, Hone Dm, et al
GENES AND IMMUNITY 2007;8(4):334-43

MHC class II tetramer guided detection of Mycobacterium tuberculosis-specific CD4(+) T cells in peripheral blood from patients with pulmonary tuberculosis
Hohn H, Kortsik C, Zehbe I, Hitzler We, Kayser K, Freitag K, et al
SCANDINAVIAN JOURNAL OF IMMUNOLOGY 2007;65(5):467-78

Reduced numbers of IL-7 receptor (CD127) expressing immune cells and IL-7-signaling defects in peripheral blood from patients with breast cancer
Vudattu Nk, Magalhaes I, Schmidt M, Seyfert-margolis V, Maeurer Mj
INTERNATIONAL JOURNAL OF CANCER 2007;121(7):1512-9

Tumor-reactive CD8(+) T-cell clones in patients after NY-ESO-1 peptide vaccination
Karbach J, Gnjatic S, Pauligk C, Bender A, Maeurer M, Schultze Jl, et al
INTERNATIONAL JOURNAL OF CANCER 2007;121(9):2042-8

Validation of peptide epitope microarray experiments and extraction of quality data
Nahtman T, Jernberg A, Mahdavifar S, Zerweck J, Schutkowski M, Maeurer M, et al
JOURNAL OF IMMUNOLOGICAL METHODS 2007;328(1-2):1-13

Different T-cell receptor (TCR) zeta chain expression in cervical cancer and its precursor lesions
Zehbe I, Schmidt M, Maeurer M, Leo C, Höckel M, Pilch H
Zentralblatt fur Gynakologie 2006;128(5):266-70

DRB1*0401-restricted human T cell clone specific for the major proinsulin73-90 epitope expresses a down-regulatory T helper 2 phenotype
Durinovic-bello I, Rosinger S, Olson Ja, Congia M, Ahmad Rc, Rickert M, et al
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 2006;103(31):11683-8

Interleukin-7 receptor (IL-7R) mediated signaling effects in immune cells : novel readout for 'immune competence'
Vudattu N, Magalhaes I, Ahmed R, Schmidt M, Khademi M, Olsson T, et al
CLINICAL IMMUNOLOGY 2006;:S116-S117

CD8aa+ T-cells represent a long-lived memory T-cell subset in patients with melanoma undergoing epitope-based tumor vaccination
Magalhaes L, Vudattu Nk, Freitag K, Karbach J, Kumar A, Zhu Z, et al
CLINICAL IMMUNOLOGY 2005;:S73-S73

Diagnosing Helicobacter pylori in vivo by confocal laser endoscopy
Kiesslich R, Goetz M, Burg J, Stolte M, Siegel E, Maeurer Mj, et al
GASTROENTEROLOGY 2005;128(7):2119-23

Differential MHC class II component expression in HPV-positive cervical cancer cells: Implication for immune surveillance
Zehbe I, Hohn H, Pilch H, Neukirch C, Freitag K, Maeurer Mj
INTERNATIONAL JOURNAL OF CANCER 2005;117(5):807-15

Elevated antigen-specific IL2 production in CD8AA+T-cells in patients with melanoma responding to therapy
Magalhaes I, Vudattu Nk, Karbach J, Juelch M, Castelli C, Jaeger E, et al
JOURNAL OF IMMUNOTHERAPY 2005;28(6):632-632

Highly focused T cell responses in latent human pulmonary Mycobacterium tuberculosis infection
Tully G, Kortsik C, Hohn H, Zehbe I, Hitzler We, Neukirch C, et al
JOURNAL OF IMMUNOLOGY 2005;174(4):2174-84

Naturally processed and HLA-B8-presented HPV16 E7 epitope recognized by T cells from patients with cervical cancer
Oerke S, Hohn H, Zehbe I, Pilch H, Schicketanz Kh, Hitzler We, et al
INTERNATIONAL JOURNAL OF CANCER 2005;114(5):766-78

New tetramer technology offers new aspects in the definition of appropriate HPV target epitopes for novel vaccine designs in cervical cancer patients
Pilch H, Schmidt M, Steiner E, Seufert R, Jensen A, Nilges K, et al
GEBURTSHILFE UND FRAUENHEILKUNDE 2005;65(3):297-302

Reduced expression of the IL-7 receptor (CD127) on CD8AA+T-cells and IL-7 signalling defects in patients with breast cancer
Vudattu Nk, Magalhaes I, Schmidt M, Maeurer M
JOURNAL OF IMMUNOTHERAPY 2005;28(6):626-627

Blood T-cell V beta transcriptome in melanoma patients
Degauque N, Schadendorf D, Brouard S, Guillet M, Sebille F, Hohn H, et al
INTERNATIONAL JOURNAL OF CANCER 2004;110(5):721-9

Definition of the HLA-A2 restricted peptides recognized by human CD8(+) effector T cells by flow-assisted sorting of the CD8(+) CD45RA(+) CD28(-) T cell subpopulation
Hohn H, Julch M, Pilch H, Kortsik C, Tully G, Neukirch C, et al
CLINICAL AND EXPERIMENTAL IMMUNOLOGY 2003;131(1):102-10

Human papillomavirus type 16 E7 peptide-directed CD8(+) T cells from patients with cervical cancer are cross-reactive with the coronavirus NS2 protein
Nilges K, Hohn H, Pilch H, Neukirch C, Freitag K, Talbot Pj, et al
JOURNAL OF VIROLOGY 2003;77(9):5464-74

Longitudinal analysis of Mycobacterium tuberculosis 19-kDa antigen-specific T cells in patients with pulmonary tuberculosis: association with disease activity and cross-reactivity to a peptide from HIVenv gp120
Hohn H, Kortsik C, Tully G, Nilges K, Necker A, Freitag K, et al
EUROPEAN JOURNAL OF IMMUNOLOGY 2003;33(6):1613-23

Rapid high efficiency sensitization of CD8(+) T cells to tumor antigens by dendritic cells leads to enhanced functional avidity and direct tumor recognition through an IL-12-dependent mechanism
Xu Sw, Koski Gk, Faries M, Bedrosian I, Mick R, Maeurer M, et al
JOURNAL OF IMMUNOLOGY 2003;171(5):2251-61

Suboptimal activation of CD8(+) T cells by melanoma-derived altered peptide ligands: Role of melan-A/MART-1 optimized analogues
Carrabba Mg, Castelli C, Maeurer Mj, Squarcina P, Cova A, Pilla L, et al
CANCER RESEARCH 2003;63(7):1560-7

Antigen-driven T-cell selection in patients with cervical cancer as evidenced by T-cell receptor analysis and recognition of autologous tumor
Pilch H, Hohn H, Neukirch C, Freitag K, Knapstein Pg, Tanner B, et al
CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY 2002;9(2):267-78

CD8+CD45RA+CD27-CD28-T-cell subset in PBL of cervical cancer patients representing CD8+T-cells being able to recognize cervical cancer associated antigens provided by HPV 16 E7
Pilch H, Hoehn H, Schmidt M, Steiner E, Tanner B, Seufert R, et al
Zentralblatt fur Gynakologie 2002;124(8-9):406-12

Identification of a naturally processed NY-ESO-1 peptide recognized by CD8+ T cells in the context of HLA-B51
Jäger E, Karbach J, Gnjatic S, Jäger D, Maeurer M, Atmaca A, et al
Cancer immunity 2002;2():12-

Impact of antigen presentation on TCR modulation and cytokine release: Implications for detection and sorting of antigen-specific CD8(+) T cells using HLA-A2 wild-type or HLA-A2 mutant tetrameric complexes
Jager E, Salter R, Castelli C, Hohn H, Freitag K, Karbach J, et al
JOURNAL OF IMMUNOLOGY 2002;168(6):2766-72

Improved detection of melanoma antigen-specific T cells expressing low or high levels of CD8 by HLA-A2 tetramers presenting a Melan-A/MART-1 peptide analogue
Maeurer Mj, Necker A, Salter Rd, Castelli C, Hohn H, Karbach J, et al
INTERNATIONAL JOURNAL OF CANCER 2002;97(1):64-71

Longitudinal analysis of the T-cell receptor (TCR)-VA and -VB repertoire in CD8(+) T cells from individuals immunized with recombinant hepatitis B surface antigen
Hohn H, Neukirch C, Freitag K, Necker A, Hitzler W, Seliger B, et al
CLINICAL AND EXPERIMENTAL IMMUNOLOGY 2002;129(2):309-17

No association between Helicobacter pylori genotypes and antibiotic resistance phenotypes within families
Zschausch Hce, Han Sr, Meyer Hgw, Maeurer Mj
HELICOBACTER 2002;7(6):364-6

Peptide-specific CD8+T-cell evolution in vivo: Response to peptide vaccination with Melan-A/MART-I
Jager E, Hohn H, Necker A, Forster R, Karbach J, Freitag K, et al
INTERNATIONAL JOURNAL OF CANCER 2002;98(3):376-88

Regulation of CD1D expression by murine tumor cells: Escape from immunosurveillance or alternate target molecules?
Fiedler T, Walter W, Reichert Te, Maeurer Mj
INTERNATIONAL JOURNAL OF CANCER 2002;98(3):389-97

The ability of variant peptides to reverse the nonresponsiveness of T lymphocytes to the wild-type sequence p53(264-272) epitope
Hoffmann Tk, Loftus Dj, Nakano K, Maeurer Mj, Chikamatsu K, Appella E, et al
JOURNAL OF IMMUNOLOGY 2002;168(3):1338-47

The T-Cell response in patients with cancer
Castelli C, Maeurer Mj
ADVANCES IN CANCER RESEARCH, VOL 86 2002;:149-93

Antigen recognition by T cells: a strong sense of structure
Maeurer M, Hohn H, Castelli C, Salter Rd, Necker A, Reichert T, et al
TRENDS IN IMMUNOLOGY 2001;22(11):599-601

Deficient expression of components of the MHC class I antigen processing machinery in human cervical carcinoma
Ritz U, Momburg F, Pilch H, Huber C, Maeurer Mj, Seliger B
INTERNATIONAL JOURNAL OF ONCOLOGY 2001;19(6):1211-20

H2-M beta 1 and H2-M beta 2 heterodimers equally promote CLIP removal in I-A(q) molecules from autoimmune-prone DBA/1 mice
Walter W, Scheuer C, Loos M, Reichert Te, Maeurer Mj
JOURNAL OF BIOLOGICAL CHEMISTRY 2001;276(14):11086-91

Human leucocyte antigen-A2 restricted and Mycobacterium tuberculosis 19-kDa antigen-specific CD8(+) T-cell responses are oligoclonal and exhibit a T-cell cytotoxic type 2 response cytokine-secretion pattern
Hohn H, Kortsik C, Nilges K, Necker A, Freitag K, Tully G, et al
IMMUNOLOGY 2001;104(3):278-88

Human papillomavirus (HPV) DNA in primary cervical cancer and in cancer free pelvic lymph nodes--correlation with clinico-pathological parameters and prognostic significance
Pilch H, Günzel S, Schäffer U, Tanner B, Brockerhoff P, Maeurer M, et al
Zentralblatt fur Gynakologie 2001;123(2):91-101

Interventional ERCP in patients with cholestasis. Degree of biliary bacterial colonization and antibiotic resistance
Kiesslich R, Holfelder M, Will D, Hahn M, Nafe B, Genitsariotis R, et al
ZEITSCHRIFT FUR GASTROENTEROLOGIE 2001;39(12):985-92

Reduced T-cell receptor CD3 zeta-chain protein and sustained CD3 epsilon expression at the site of mycobacterial infection
Seitzer U, Kayser K, Hohn H, Entzian P, Wacker Hh, Ploetz S, et al
IMMUNOLOGY 2001;104(3):269-77

Segregation of effector mechanisms in a tumour-specific CD8(+) T-cell clone correlates with CD30 expression
Sun Y, Song M, Maeurer Mj, Schadendorf D
SCANDINAVIAN JOURNAL OF IMMUNOLOGY 2001;54(3):314-20

The presence of HPV DNA in cervical cancer: Correlation with clinico-pathologic parameters and prognostic significance: 10 years experience at the Department of Obstetrics and Gynecology of the Mainz University
Pilch H, Gunzel S, Schafer U, Tanner B, Brockerhoff P, Maeurer M, et al
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER 2001;11(1):39-48

Toxoplasma gondii down-regulates MHC class II gene expression and antigen presentation by murine macrophages via interference with nuclear translocation of STAT1 alpha
Luder Cgk, Walter W, Beuerle B, Maeurer Mj, Gross U
EUROPEAN JOURNAL OF IMMUNOLOGY 2001;31(5):1475-84

Antigen-processing machinery breakdown and tumor growth
Seliger B, Maeurer Mj, Ferrone S
IMMUNOLOGY TODAY 2000;21(9):455-64

Cervical cancer cells present HPV-E7 epitope to CD4+tumor infiltrating lymphocytes (TIL) in association with histocompatibility leukocyte antigen (HLA) DR4 - Identification of HPV-peptides by CD4+T-cells
Pilch H, Hohn H, Gunzel S, Schaffer U, Seelig R, Seeliger B, et al
GEBURTSHILFE UND FRAUENHEILKUNDE 2000;60(1):35-40

Clonal expansion of Melan A-specific cytotoxic T lymphocytes in a melanoma patient responding to continued immunization with melanoma-associated peptides
Jager E, Maeurer M, Hohn H, Karbach J, Jager D, Zidianakis Z, et al
INTERNATIONAL JOURNAL OF CANCER 2000;86(4):538-47

Expansion of the CD8+CD45RA+CD27-CD28-T-cell subset in patients with HPV-associated cervical cancer and its precursors
Pilch H, Gunzel S, Freitag C, Schaffer U, Tanner B, Knapstein Pg, et al
GEBURTSHILFE UND FRAUENHEILKUNDE 2000;60(9):464-468

Granulomatous hepatitis in an immunocompromised patient diagnosed by minilaparoscopy
Helmreich-becker I, Maeurer M, Galle Pr, Lohse Aw
ENDOSCOPY 2000;32(5):S27-8

H2-M, a facilitator of MHC class II peptide loading, and its negative modulator H2-O are differentially expressed in response to proinflammatory cytokines
Walter W, Scheuer C, Lingnau K, Reichert Te, Schmitt E, Loos M, et al
IMMUNOGENETICS 2000;51(10):794-804

Helicobacter pylori: Clonal population structure and restricted transmission within families revealed by molecular typing
Han Sr, Zschausch Hce, Meyer Hgw, Schneider H, Loos M, Bhakdi S, et al
JOURNAL OF CLINICAL MICROBIOLOGY 2000;38(10):3646-51

Hepatic granuloma due to Propionibacterium acnes in a patient with acute myelogenous leukemia
Ullmann Aj, Helmreich-becker I, Maeurer Mj, Han Sr, Heussel Cp, Koehler Hh, et al
CLINICAL INFECTIOUS DISEASES 2000;30(1):219-20

Human papillomavirus type 33 E7 peptides presented by HLA-DR*0402 to tumor-infiltrating T cells in cervical cancer
Hohn H, Pilch H, Gunzel S, Neukirch C, Freitag K, Necker A, et al
JOURNAL OF VIROLOGY 2000;74(14):6632-6

Humoral autoreactivity directed against surfactant protein-A (SP-A) in rheumatoid arthritis synovial fluids
Trinder Pke, Hickling Tp, Sim Rb, Brackertz D, Loos M, Maeurer Mj
CLINICAL AND EXPERIMENTAL IMMUNOLOGY 2000;120(1):183-7

Identification of a unique Helicobacter species by 16S rRNA gene analysis in an abdominal abscess from a patient with X-linked hypogammaglobulinemia
Han Sr, Schindel C, Genitsariotis R, Marker-hermann E, Bhakdi S, Maeurer Mj
JOURNAL OF CLINICAL MICROBIOLOGY 2000;38(7):2740-2

Interleukin-7 or interleukin-15 enhances survival of Mycobacterium tuberculosis-infected mice
Maeurer Mj, Trinder P, Hommel G, Walter W, Freitag K, Atkins D, et al
INFECTION AND IMMUNITY 2000;68(5):2962-70

MHC class II antigen presentation pathway in marine tumours: tumour evasion from immunosurveillance?
Walter W, Lingnau K, Schmitt E, Loos M, Maeurer Mj
BRITISH JOURNAL OF CANCER 2000;83(9):1192-201

Persistent Legionella infection in a patient after bone marrow transplantation
Schindel C, Siepmann U, Han Sr, Ullmann Aj, Mayer E, Fischer T, et al
JOURNAL OF CLINICAL MICROBIOLOGY 2000;38(11):4294-5

CD4(+) tumor-infiltrating lymphocytes in cervical cancer recognize HLA-DR-restricted peptides provided by human papillomavirus-E7
Hohn H, Pilch H, Gunzel S, Neukirch C, Hilmes C, Kaufmann A, et al
JOURNAL OF IMMUNOLOGY 1999;163(10):5715-22

Constitutive and IFN-gamma regulated expression of IL-7 and IL-15 in human renal cell cancer
Trinder P, Seitzer U, Gerdes J, Seliger B, Maeurer M
INTERNATIONAL JOURNAL OF ONCOLOGY 1999;14(1):23-31

Cytotoxic T lymphocytes define multiple peptide isoforms derived from the melanoma-associated antigen MART-1/Melan-A
Jager E, Hohn H, Karbach J, Momburg F, Castelli C, Knuth A, et al
INTERNATIONAL JOURNAL OF CANCER 1999;81(6):979-84

Differential expression of alternative H2-M isoforms in B cells, dendritic cells and macrophages by proinflammatory cytokines
Walter W, Loos M, Maeurer Mj
MOLECULAR IMMUNOLOGY 1999;36(11-12):733-43

Functional definition of a B cell epitope, KGEQGEPGA, on Clq the Fc-binding subunit of the first component of complement
Trinder Pke, Marker-hermann E, Loos M, Maeurer Mj
SCANDINAVIAN JOURNAL OF IMMUNOLOGY 1999;50(6):635-41

Interleukin-15 in mycobacterial infection of antigen-presenting cells
Maeurer M, Seliger B, Trinder P, Gerdes J, Seitzer U
SCANDINAVIAN JOURNAL OF IMMUNOLOGY 1999;50(3):280-8

Monoclonal TCR mRNA transcripts are preferentially detected in the TCR variable alpha chain in CD8(+) T-lymphocytes: Implications for immunomonitoring
Hohn H, Reichert T, Neukirch C, Pilch H, Maeurer Mj
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE 1999;3(2):139-44

One-step polymerase chain reaction-based typing of Helicobacter pylori vacA gene: association with gastric histopathology
Han Sr, Schneider T, Loos M, Bhakdi S, Maeurer Mj
MEDICAL MICROBIOLOGY AND IMMUNOLOGY 1999;188(3):131-8

Stable and unstable amoxicillin resistance in Helicobacter pylori: Should antibiotic resistance testing be performed prior to eradication therapy?
Han Sr, Bhakdi S, Maeurer Mj, Schneider T, Gehring S
JOURNAL OF CLINICAL MICROBIOLOGY 1999;37(8):2740-1

Autologous human dendriphages pulsed with synthetic or natural tumor peptides elicit tumor-specific CTLs in vitro
Tjandrawan T, Martin Dm, Maeurer Mj, Castelli C, Lotze Mt, Storkus Wj
JOURNAL OF IMMUNOTHERAPY 1998;21(2):149-57

Interleukin-7 (IL-7) knockout mice. Implications for lymphopoiesis and organ-specific immunity
Maeurer Mj, Lotze Mt
International reviews of immunology 1998;16(3-4):309-22

vacA genotypes and genetic diversity in clinical isolates of Helicobacter pylori
Han Sr, Schreiber Hj, Bhakdi S, Loos M, Maeurer Mj
CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY 1998;5(2):139-45

Altered (Oxidized) C1q induces a rheumatoid arthritis-like destructive and chronic inflammation in joint structures in arthritis-susceptible rats
Trinder Pke, Maeurer Mj, Stoerkel Ss, Loos M
CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY 1997;82(2):149-56

Interleukin-7 (IL-7) in colorectal cancer: IL-7 is produced by tissues from colorectal cancer and promotes preferential expansion of tumour infiltrating lymphocytes
Maeurer Mj, Walter W, Martin D, Zitvogel L, Elder E, Storkus W, et al
SCANDINAVIAN JOURNAL OF IMMUNOLOGY 1997;45(2):182-92

TAP off - Tumors on
Seliger B, Maeurer Mj, Ferrone S
IMMUNOLOGY TODAY 1997;18(6):292-9

Tumor recognition by the cellular immune system: new aspects of tumor immunology
Maeurer Mj, Lotze Mt
International reviews of immunology 1997;14(2-3):97-132

Amino acid substitutions at position 97 in HLA-A2 segregate cytolysis from cytokine release in MART-1/Melan-A peptide AAGIGILTV-specific cytotoxic T lymphocytes
Maeurer Mj, Chan Hw, Karbach J, Salter Rd, Knuth A, Lotze Mt, et al
EUROPEAN JOURNAL OF IMMUNOLOGY 1996;26(11):2613-23

Detection of naturally processed and HLA-A1-presented melanoma T-cell epitopes defined by CD8(+) T-cells' release of granulocyte-macrophage colony-stimulating factor but not by cytolysis
Maeurer Mj, Martin D, Elder E, Storkus Wj, Lotze Mt
CLINICAL CANCER RESEARCH 1996;2(1):87-95

H2-M polymorphism in mice susceptible to collagen-induced arthritis involves the peptide binding groove
Walter W, Loos M, Maeurer Mj
IMMUNOGENETICS 1996;44(1):19-26

Human intestinal V delta 1(+) T lymphocytes recognize tumor cells of epithelial origin
Maeurer Mj, Martin D, Walter W, Liu Kh, Zitvogel L, Halusczcak K, et al
JOURNAL OF EXPERIMENTAL MEDICINE 1996;183(4):1681-96

Interleukin-12 and B7.1 co-stimulation cooperate in the induction of effective antitumor immunity and therapy of established tumors
Zitvogel L, Robbins Pd, Storkus Wj, Clarke Mr, Maeurer Mj, Campbell Rl, et al
EUROPEAN JOURNAL OF IMMUNOLOGY 1996;26(6):1335-41

Multiple melanoma-associated epitopes recognized by HLA-A3-restricted CTLs and shared by melanomas but not melanocytes
Mazzocchi A, Storkus Wj, Traversari C, Tarsini P, Maeurer Mj, Rivoltini L, et al
JOURNAL OF IMMUNOLOGY 1996;157(7):3030-8

New treatment options for patients with melanoma: Review of melanoma-derived T-cell epitope-based peptide vaccines
Maeurer Mj, Storkus Wj, Kirkwood Jm, Lotze Mt
MELANOMA RESEARCH 1996;6(1):11-24

Recognition of human renal cell carcinoma and melanoma by HLA-A2-restricted cytotoxic T lymphocytes is mediated by shared peptide epitopes and up-regulated by interferon-gamma
Bernhard H, Maeurer Mj, Jager E, Wolfel T, Schneider J, Karbach J, et al
SCANDINAVIAN JOURNAL OF IMMUNOLOGY 1996;44(3):285-92

The collagen-like component of the complement system, C1q, is recognized by 7 S autoantibodies and is functionally impaired in synovial fluids of patients with rheumatoid arthritis
Trinder Pke, Maeurer Mj, Brackertz D, Loos M
IMMUNOLOGY 1996;87(3):355-61

Tumor associated antigens in human renal cell carcinoma: MHC restricted recognition by cytotoxic T lymphocytes
Bernhard H, Jager E, Maeurer Mj, Zumbuschenfelde Khm, Knuth A
TISSUE ANTIGENS 1996;48(1):22-31

Tumor escape from immune recognition - Lethal recurrent melanoma in a patient associated with downregulation of the peptide transporter protein TAP-1 and loss of expression of the immunodominant MART-1/Melan-A antigen
Maeurer Mj, Gollin Sm, Martin D, Swaney W, Bryant J, Castelli C, et al
JOURNAL OF CLINICAL INVESTIGATION 1996;98(7):1633-41

Tumor escape from immune recognition: Loss of HLA-A2 melanoma cell surface expression is associated with a complex rearrangement of the short arm of chromosome 6(1)
Maeurer Mj, Gollin Sm, Storkus Wj, Swaney W, Karbach J, Martin D, et al
CLINICAL CANCER RESEARCH 1996;2(4):641-52

AUTOREACTIVITY TO MOUSE C1Q IN A MURINE MODEL OF SLE
Trinder Pke, Maeurer Mj, Schorlemmer Hu, Loos M
RHEUMATOLOGY INTERNATIONAL 1995;15(3):117-20

Cytolytic T-cell clones define HLA-A2-restricted human cutaneous melanoma peptide epitopes: correlation with T-cell receptor usage
Maeurer Mj, Hurd S, Martin Dm, Storkus Wj, Lotze Mt
The cancer journal from Scientific American 1995;1(2):162-70

HOST IMMUNE-RESPONSE IN RENAL-CELL CANCER - INTERLEUKIN-4 (IL-4) AND IL-10 MESSENGER-RNA ARE FREQUENTLY DETECTED IN FRESHLY COLLECTED TUMOR-INFILTRATING LYMPHOCYTES
Maeurer Mj, Martin Dm, Castelli C, Elder E, Leder G, Storkus Wj, et al
CANCER IMMUNOLOGY IMMUNOTHERAPY 1995;41(2):111-21

Human intestinal V(delta)1+T cells obtained from patients with colon cancer respond exclusively to SEB but not to SEA
Maeurer M, Zitvogel L, Elder E, Storkus Wj, Lotze Mt
NATURAL IMMUNITY 1995;14(4):188-97

MASS-SPECTROMETRIC IDENTIFICATION OF A NATURALLY PROCESSED MELANOMA PEPTIDE RECOGNIZED BY CD8(+) CYTOTOXIC T-LYMPHOCYTES
Castelli C, Storkus Wj, Maeurer Mj, Martin Dm, Huang Ec, Pramanik Bn, et al
JOURNAL OF EXPERIMENTAL MEDICINE 1995;181(1):363-8

TCR USAGE IN CTLS RECOGNIZING MELANOMA MELANOCYTE ANTIGENS
Maeurer Mj, Martin Dm, Storkus Wj, Lotze Mt
IMMUNOLOGY TODAY 1995;16(12):603-4

Show all publications